Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

There remains a role for neurologic testing of patients with erectile dysfunction

There remains a role for neurologic testing of patients with erectile dysfunction In this era of modern medicine and phosphodiesterase-5 inhibitors (PDE5i), the range of treatment options for ED and the variety of solutions for its possible causes compel the physician to offer a more comprehensive yet targeted treatment. As clinicians, we are obligated to establish the cause of impotence. Whether it is vascular, neurologic, or psychosexual, we need to evaluate and classify the severity of the dysfunction and to select the best therapeutic option that is acceptable to the patient and addresses his pathology [6]. For example, due to poor treatment success rates with PDE5i for neurogenic ED, it would be wiser to recognize the neurologic dysfunction beforehand and be able to provide a treatment modality that would enhance success of treatment for these speci.c cases. The key factor for deciding on neurologic evaluation lies in the medical history intake, which should focus on characterizing the problem (severity, onset, and duration), but at the same time should be oriented to evaluating the need for any specialized testing. Neurologic tests are still being re.ned and improved to achieve better and more accurate results in a simpler fashion. Clinical studies are still required to de.ne the exact place of these tests in the diagnostic workup for both male and female sexual dysfunction. In this dynamic process, we must continue to use and perfect these tests in order to make them even more applicable for routine clinical use. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Sexual Health Reports Springer Journals

There remains a role for neurologic testing of patients with erectile dysfunction

Current Sexual Health Reports , Volume 3 (1) – May 29, 2006

Loading next page...
 
/lp/springer-journals/there-remains-a-role-for-neurologic-testing-of-patients-with-erectile-k2OHAeac4B
Publisher
Springer Journals
Copyright
Copyright © 2006 by Current Science Inc
Subject
Medicine & Public Health; Urology; Endocrinology
ISSN
1548-3584
eISSN
1548-3592
DOI
10.1007/s11930-006-0017-3
Publisher site
See Article on Publisher Site

Abstract

In this era of modern medicine and phosphodiesterase-5 inhibitors (PDE5i), the range of treatment options for ED and the variety of solutions for its possible causes compel the physician to offer a more comprehensive yet targeted treatment. As clinicians, we are obligated to establish the cause of impotence. Whether it is vascular, neurologic, or psychosexual, we need to evaluate and classify the severity of the dysfunction and to select the best therapeutic option that is acceptable to the patient and addresses his pathology [6]. For example, due to poor treatment success rates with PDE5i for neurogenic ED, it would be wiser to recognize the neurologic dysfunction beforehand and be able to provide a treatment modality that would enhance success of treatment for these speci.c cases. The key factor for deciding on neurologic evaluation lies in the medical history intake, which should focus on characterizing the problem (severity, onset, and duration), but at the same time should be oriented to evaluating the need for any specialized testing. Neurologic tests are still being re.ned and improved to achieve better and more accurate results in a simpler fashion. Clinical studies are still required to de.ne the exact place of these tests in the diagnostic workup for both male and female sexual dysfunction. In this dynamic process, we must continue to use and perfect these tests in order to make them even more applicable for routine clinical use.

Journal

Current Sexual Health ReportsSpringer Journals

Published: May 29, 2006

References